Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Optimi Health Corp (OPTI.CN)

Optimi Health Corp (OPTI.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 33,849
  • Shares Outstanding, K 89,078
  • Annual Sales, $ 181 K
  • Annual Income, $ -5,195 K
  • 60-Month Beta 1.46
  • Price/Sales 140.38
  • Price/Cash Flow N/A
  • Price/Book 2.80
Trade OPTI.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.06
  • Most Recent Earnings $-0.01 on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Drug Specialty & Generic

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2500 +50.00%
on 04/18/24
0.3850 -2.60%
on 05/09/24
+0.1150 (+44.23%)
since 04/09/24
3-Month
0.2100 +78.57%
on 03/22/24
0.3850 -2.60%
on 05/09/24
+0.0550 (+17.19%)
since 02/09/24
52-Week
0.1500 +150.00%
on 12/12/23
0.5800 -35.34%
on 01/03/24
+0.1400 (+59.57%)
since 05/09/23

Most Recent Stories

More News
Early Warning Press Release in Accordance with National Instrument 62-103

Vancouver, British Columbia--(Newsfile Corp. - April 4, 2024) - Cathay Visions Enterprises Ltd. (the "Acquiror") acquired 110,000 common shares (each a "Common Share") of Optimi Health Corp. (the "Issuer")...

OPTI.CN : 0.3800 (unch)
Stocks in play: Optimi Health Corp

Announces the completion of its proprietary preclinical MDMA drug candidate OPTI-MHCL for use in drug ...

OPTI.CN : 0.3800 (unch)
Stocks in play: Optimi Health Corp

Announces the expansion of its sales network in Canada. To further scale the sales and distribution ...

OPTI.CN : 0.3800 (unch)
Psychedelic Drugs Prove Their Worth In Clinical Trials

Novel psychedelic drugs have continuously proven their worth in clinical trials. Just recently, one company revealed that it was in the process of finalizing its Phase 1 first-in-human clinical trial plan...

OPTI.CN : 0.3800 (unch)
ATAI : 2.06 (+2.49%)
MNMD : 9.00 (-6.35%)
MMED.NE : 14.9000 (+9.48%)
CMPS : 8.60 (+1.18%)
OPTHF : 0.2765 (-0.86%)
CYBN : 0.3713 (+0.35%)
Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease

A Toronto-based biotech firm is developing a new psychedelic medicine to cure Alzheimer’s disease, announcing recently that it has gotten approval from Argentina’s regulators to begin a Phase ll clinical...

OPTI.CN : 0.3800 (unch)
SEEL : 0.2800 (-3.11%)
NUMI.TO : 0.0750 (unch)
NUMIF : 0.0547 (+0.18%)
ATAI : 2.06 (+2.49%)
OPTHF : 0.2765 (-0.86%)
TNXP : 0.1806 (+1.75%)
TAK : 13.36 (+2.30%)
Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease

FN Media Group Presents Microsmallcap.com Market Commentary   New York, NY – October 5, 2022 – A Toronto-based biotech firm is developing a new psychedelic medicine to cure Alzheimer’s disease,...

SEEL : 0.2800 (-3.11%)
TAK : 13.36 (+2.30%)
ATAI : 2.06 (+2.49%)
TNXP : 0.1806 (+1.75%)
OPTI.CN : 0.3800 (unch)
OPTHF : 0.2765 (-0.86%)
Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer's Disease

/PRNewswire/ -- A Toronto-based biotech firm is developing a new psychedelic medicine to cure Alzheimer's disease, announcing recently that it has gotten...

OPTI.CN : 0.3800 (unch)
OPTHF : 0.2765 (-0.86%)
SEEL : 0.2800 (-3.11%)
TAK : 13.36 (+2.30%)
ATAI : 2.06 (+2.49%)
TNXP : 0.1806 (+1.75%)
Optimi Health and ATMA Journey Centers to Send a Clinical Trial Application to Health Canada for Phase I Natural Psilocybin and MDMA

Optimi Health Corp. (CSE:OPTI) (OTCQX:OPTHF) is a Canadian company that makes natural, scalable, and easy-to-get psychedelic and functional mushrooms, as well as synthetic formulations, to help people...

OPTI.CN : 0.3800 (unch)
OPTHF : 0.2765 (-0.86%)
Stocks in play: Optimi Health

Announces that it has completed what it believes to be the largest legal natural psilocybin harvest ...

OPTI.CN : 0.3800 (unch)
Stocks in play: Optimi Health

Announces that it has entered into an agreement with Avida Global, a privately-held UK-based producer ...

OPTI.CN : 0.3800 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing, and distribution of raw mushroom biomass. It also intends to cultivate,...

See More

Key Turning Points

3rd Resistance Point 0.4200
2nd Resistance Point 0.4000
1st Resistance Point 0.3900
Last Price 0.3800
1st Support Level 0.3600
2nd Support Level 0.3400
3rd Support Level 0.3300

See More

52-Week High 0.5800
Fibonacci 61.8% 0.4157
Last Price 0.3800
Fibonacci 50% 0.3650
Fibonacci 38.2% 0.3143
52-Week Low 0.1500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar